Chronic inflammation is correlated with percentage of body fat independent of the burden of infection

Inflammation

Volumn 35, Issue 4, 2012, Pages 1322-1329

  Vahdat, Katayoun ^a   Azizi, Fatemeh ^a   Zandi, Keivan ^a   Assadi, Majid ^a   Nabipour, Iraj ^a  

^a BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adipose tissue; Body fat; Burden of infection; C reactive protein; Obesity

Indexed keywords

C REACTIVE PROTEIN; HIGH SENSITIVITY C REACTIVE PROTEIN; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; BLOOD ANALYSIS; BODY FAT; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC INFLAMMATION; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HELICOBACTER PYLORI; HERPES SIMPLEX VIRUS 1; HUMAN; IMPEDANCE; MALE; MULTIPLE REGRESSION; PATHOGEN LOAD; PROTEIN DETERMINATION; RANDOMIZATION;

ADIPOSE TISSUE; ADULT; AGED; BODY MASS INDEX; C-REACTIVE PROTEIN; CAROTID ARTERY DISEASES; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION; MALE; MIDDLE AGED;

BACTERIA (MICROORGANISMS); CHLAMYDOPHILA PNEUMONIAE; CYTOMEGALOVIRUS; HELICOBACTER PYLORI; HUMAN HERPESVIRUS 1;

EID: 84866738829     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9445-6     Document Type: Article

References (42)

1. Fantuzzi, G. 2005. Adipose tissue, adipokines, and inflammation. The Journal of Allergy and Clinical Immunology 115: 911-919.
2. Després, J.P. 2006. Abdominal obesity: The most prevalent cause of the metabolic syndrome and related cardiometabolic risk. European Heart Journal Supplements 8: B4-B12.
3. Kim, K., R.J. Valentine, Y. Shin, and K. Gong. 2008. Associations of visceral adiposity and exercise participation with C-reactive protein, insulin resistance, and endothelial dysfunction in Korean healthy adults. Metabolism 57: 1181-1189.
4. Jialal, I., S. Devaraj, and S.K. Venugopal. 2004. C-reactive protein: Risk marker or mediator in atherothrombosis? Hypertension 44: 6-11.
5. Pearson, T.A., G.A. Mensah, R.W. Alexander, J.L. Anderson, R.O. Cannon 3rd, M. Criqui, Centers for Disease Control and Prevention, American Heart Association, et al. 2003. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107: 499-511.
6. Ford, E.S. 1999. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 22: 1971-1977.
7. Hak, A.E., C.D. Stehouwer, M.L. Bots, K.H. Polderman, C.G. Schalkwijk, I.C. Westendorp, et al. 1999. Associations of Creactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-Aged women. Arteriosclerosis, Thrombosis, and Vascular Biology 19: 1986-1991.
8. Heilbronn, L.K., and P.M. Clifton. 2002. C-reactive protein and coronary artery disease: influence of obesity, caloric restriction and weight loss. The Journal of Nutritional Biochemistry 13: 316-321.
9. Ziccardi, P., F. Nappo, G. Giugliano, K. Esposito, R. Marfella, M. Cioffi, et al. 2002. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105: 804-809.
10. Forouhi, N.G., N. Sattar, and P.M. McKeigue. 2001. Relation of Creactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. International Journal of Obesity and Related Metabolic Disorders 25: 1327-1331.
11. Lemieux, I., A. Pascot, D. Prud'homme, N. Alméras, P. Bogaty, A. Nadeau, et al. 2001. Elevated C-reactive protein: Another component of the atherothrombotic profile of abdominal obesity. Arteriosclerosis, Thrombosis, and Vascular Biology 21: 961-967.
12. Pou, K.M., J.M. Massaro, U. Hoffmann, R.S. Vasan, P. Maurovich-Horvat, M.G. Larson, et al. 2007. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: The Framingham Heart Study. Circulation 116: 1234-1241.
13. Faber, D.R., Y. van der Graaf, J. Westerink, and F.L.J. Visseren. 2010. Increased visceral adipose tissue mass is associated with increased C-reactive protein in patients with manifest vascular diseases. Atherosclerosis 212: 274-280.
14. Despres, J.P. 2011. CRP: star trekking the galaxy of risk markers. Lancet 377: 441-442.
15. Ebrahimi, A., I. Nabipour, K. Vahdat, S.M. Jafari, M. Fouladvand, M. Assadi, et al. 2009. High sensitivity C-reactive protein is associated with the metabolic syndrome independent to viral and bacterial pathogen burden. Diabetes Research and Clinical Practice 84: 296-302.
16. Zhu, J., A.A. Quyyumi, J.E. Norman, G. Csako, M.A. Waclawiw, G.M. Shearer, et al. 2000. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. The American Journal of Cardiology 85: 140-146.
17. Adiloglu, A.K., R. Can, C. Nazli, A. Ocal, O. Ergene, G. Tinaz, et al. 2005. Ectasia and severe atherosclerosis: Relationships with Chlamydia pneumoniae, Helicobacter pylori, and inflammatory markers. Texas Heart Institute Journal 32: 21-27.
18. Koziolek, M., B. Krzyzanowska-Swiniarska, I. Maczynska, T. Miazgowski, and S. Giedrys-Kalemba. 2008. The association between past The association between past Chlamydia pneumoniae infection and markers of chronic inflammation in obese women. European Journal of Clinical Microbiology and Infectious Diseases 27: 415-421.
19. Fernandez-Real, J.M., M.J. Ferri, J. Vendrell, and W. Ricart. 2007. Burden of infection and fat mass in healthy middle-Aged men. Obesity (Silver Spring) 15: 245-252.
20. Epstein, S.E., Y.F. Zhou, and J. Zhu. 1999. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 100: e20-e28.
21. Nabipour, I., K. Vahdat, S.M. Jafari, S. Beigi, M. Assadi, F. Azizi, et al. 2008. Elevated high sensitivity C-reactive protein is associated with type 2 diabetes mellitus: The Persian Gulf Healthy Heart Study. Endocrine Journal 55: 717-722.
22. Lukaski, H.C., P.E. Johnson, W.W. Bolonchuk, and G.I. Lykken. 1985. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. American Journal of Clinical Nutrition 41: 810-817.
23. Lintsi, M., H. Kaarma, and I. Kull. 2004. Comparison of hand-Tohand bioimpedance and anthropometry equations versus dualenergy X-ray absorptiometry for the assessment of body fat percentage in 17-18-year-old conscripts. Clinical Physiology and Functional Imaging 24: 85-90.
24. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197.
25. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. 2001. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). The Journal of the American Medical Association 285: 2486-2497.
26. Kobayashi, J., S. Murano, I. Kawamura, F. Nakamura, Y. Murase, M.A. Kawashiri, et al. 2006. The relationship of percent body fat by bioelectrical impedance analysis with blood pressure, and glucose and lipid parameters. Journal of Atherosclerosis and Thrombosis 13: 221-226.
27. Roubenoff, R., G.E. Dallal, and P.W. Wilson. 1995. Predicting body fatness: The body mass index vs estimation by bioelectrical impedance. American Journal of Public Health 85: 726-728.
28. Zhu, S., Z. Wang, W. Shen, S.B. Heymsfield, and S. Heshka. 2003. Percentage body fat ranges associated with metabolic syndrome risk: Results based on the third National Health and Nutrition Examination Survey (1988-1994). American Journal of Clinical Nutrition 78: 228-235.
29. Greenfield, J.R., K. Samaras, A.B. Jenkins, P.J. Kelly, T.D. Spector, J.R. Gallimore, et al. 2004. Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation 109: 3022-3028.
30. Thorand, B., J. Baumert, A. Doring, C. Herder, H. Kolb, W. Rathmann, et al. 2006. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 184: 216-224.
31. Festa, A., R. D'Agostino Jr., K. Williams, A.J. Karter, E.J. Mayer-Davis, R.P. Tracy, et al. 2001. The relation of body fat mass and distribution to markers of chronic inflammation. International Journal of Obesity and Related Metabolic Disorders 25: 1407-1415.
32. Lin, C.C., S.L. Kardia, C.I. Li, C.S. Liu, M.M. Lai, W.Y. Lin, et al. 2010. The relationship of high sensitivity C-reactive protein to percent body fat mass, body mass index, waist-To-hip ratio, and waist circumference in a Taiwanese population. BMC Public Health 10: 579.
33. Trayhurn, P., and J.H. Beattie. 2001. Physiological role of adipose tissue: White adipose tissue as an endocrine and secretory organ. Proceedings of the Nutrition Society 60: 329-339.
34. Weisberg, S.P., D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. The Journal of Clinical Investigation 112: 1796-1808.
35. McDade, T.W., J.N. Rutherford, L. Adair, and C. Kuzawa. 2008. Adiposity and pathogen exposure predict C-reactive protein in Filipino women. Journal of Nutrition 138: 2442-2447.
36. Thjodleifsson, B., I. Olafsson, D. Gislason, T. Gislason, R. Jogi, and C. Janson. 2008. Infections and obesity: A multinational epidemiological study. Scandinavian Journal of Infectious Diseases 40: 381-386.
37. Pannacciulli, N., F.P. Cantatore, A. Minenna, et al. 2001. Creactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. International Journal of Obesity and Related Metabolic Disorders 25: 1416-1420.
38. Park, H.S., J.Y. Park, and R. Yu. 2005. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-Alpha and IL-6. Diabetes Research and Clinical Practice 69: 29-35.
39. Nabipour, I., M. Amiri, S.R. Imami, S.M. Jahfari, A. Nosrati, D. Iranpour, et al. 2008. Unhealthy lifestyles and ischaemic electrocardiographic abnormalities: The Persian Gulf Healthy Heart Study. Eastern Mediterranean Health Journal 14: 858-868.
40. Nabipour, I., M. Amiri, S.R. Imami, S.M. Jahfari, E. Shafeiae, A. Nosrati, et al. 2007. The metabolic syndrome and nonfatal ischemic heart disease; a population-based study. International Journal of Cardiology 118: 48-53.
41. Pateyjohns, I.R., G.D. Brinkworth, J.D. Buckley, M. Noakes, and P.M. Clifton. 2006. Comparison of three bioelectrical impedance methods with DXA in overweight and obese men. Obesity (Silver Spring) 14: 2064-2070.
42. Nabipour, I., K. Vahdat, S.M. Jafari, R. Pazoki, and Z. Sanjdideh. 2006. The association of metabolic syndrome and Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus type 1: The Persian Gulf Healthy Heart Study. Cardiovascular Diabetology 5: 25.